AU2003295500A1 - Nuclear receptor-based diagnostic, therapeutic, and screening methods - Google Patents
Nuclear receptor-based diagnostic, therapeutic, and screening methodsInfo
- Publication number
- AU2003295500A1 AU2003295500A1 AU2003295500A AU2003295500A AU2003295500A1 AU 2003295500 A1 AU2003295500 A1 AU 2003295500A1 AU 2003295500 A AU2003295500 A AU 2003295500A AU 2003295500 A AU2003295500 A AU 2003295500A AU 2003295500 A1 AU2003295500 A1 AU 2003295500A1
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- screening methods
- nuclear receptor
- based diagnostic
- diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42630502P | 2002-11-14 | 2002-11-14 | |
| US60/426,305 | 2002-11-14 | ||
| PCT/US2003/036229 WO2004045369A2 (en) | 2002-11-14 | 2003-11-12 | Nuclear receptor-based diagnostic, therapeutic, and screening methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003295500A1 true AU2003295500A1 (en) | 2004-06-15 |
| AU2003295500A8 AU2003295500A8 (en) | 2004-06-15 |
Family
ID=32326328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003295500A Abandoned AU2003295500A1 (en) | 2002-11-14 | 2003-11-12 | Nuclear receptor-based diagnostic, therapeutic, and screening methods |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003295500A1 (en) |
| WO (1) | WO2004045369A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005075990A2 (en) * | 2004-02-07 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a2 (nr4a2) |
| WO2005075983A2 (en) * | 2004-02-07 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3) |
| WO2005085865A2 (en) * | 2004-03-09 | 2005-09-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb) |
| WO2006005460A2 (en) * | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 2, group e, member 1 (nr2e1) |
| US9484123B2 (en) | 2011-09-16 | 2016-11-01 | Prc-Desoto International, Inc. | Conductive sealant compositions |
| WO2014071281A1 (en) | 2012-11-02 | 2014-05-08 | The Johns Hopkins University | Dna methylation biomarkers of post-partum depression risk |
| US9855314B2 (en) | 2013-03-01 | 2018-01-02 | The Schepens Eye Research Insititute, Inc. | Methods for modulating development and function of photoreceptor cells |
| RU2716479C1 (en) * | 2018-09-13 | 2020-03-11 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" | Method for prediction of response to cardiac resynchronising therapy in patients with chronic heart failure |
| RU2747679C1 (en) * | 2020-07-09 | 2021-05-12 | федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации | Method for predicting clinical course of highly differentiated neuroendocrine pancreatic tumors |
| CN112725438B (en) * | 2021-02-05 | 2023-08-22 | 深圳市宝安区妇幼保健院 | Endometrial polyp methylation marker combination, detection kit and application |
| CN115851914A (en) * | 2022-12-12 | 2023-03-28 | 复旦大学附属眼耳鼻喉科医院 | Application of LOC107985869 in preparation of ophthalmoplegia specific auxiliary diagnostic reagent |
| CN116539902A (en) * | 2023-07-05 | 2023-08-04 | 中国医学科学院北京协和医院 | Application of differential lipid molecules as lipid markers and kit |
| CN116539901A (en) * | 2023-07-06 | 2023-08-04 | 中国医学科学院北京协和医院 | Application of differential metabolite as diagnostic marker and kit |
-
2003
- 2003-11-12 AU AU2003295500A patent/AU2003295500A1/en not_active Abandoned
- 2003-11-12 WO PCT/US2003/036229 patent/WO2004045369A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004045369A3 (en) | 2007-03-01 |
| WO2004045369A2 (en) | 2004-06-03 |
| AU2003295500A8 (en) | 2004-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002316576A1 (en) | Diagnostic and screening methods for bladder cancer | |
| EP1588142A3 (en) | Methods for diagnosing rcc and other solid tumors | |
| AU2003261073A1 (en) | Combined diagnostic and therapeutic ultrasound system | |
| AU2002339844A1 (en) | Screening and therapeutic methods for promoting wakefulness and sleep | |
| AU2003240959A1 (en) | Microarray detector and methods | |
| AU2002243549A1 (en) | Diagnostic and monitoring methods for cancer | |
| AU2003282642A1 (en) | Blood testing apparatus | |
| AU2003281207A1 (en) | Electrocardiogram analysis device and method thereof | |
| AU2002952993A0 (en) | Therapeutic and diagnostic agents | |
| AU2002309750A1 (en) | Screening, diagnostic and therapeutic methods relating to riz | |
| AU2002366703A1 (en) | Anti-seismic rescue apparatus | |
| GB2394052B (en) | Walkaway tomographic monitoring | |
| AU2003295500A1 (en) | Nuclear receptor-based diagnostic, therapeutic, and screening methods | |
| AU2003268032A1 (en) | Composition and methods for treatment and screening | |
| AU2003224956A1 (en) | Reference structures and reference structure enhanced tomography | |
| AU2003255544A1 (en) | Tumor specific oligosaccharide epitopes and use thereof | |
| AU2003210541A1 (en) | Health improvement systems and methods | |
| AU2003274588A1 (en) | Diagnostic x-ray system | |
| AU2003289282A1 (en) | Diagnosis device and diagnosis method | |
| EP1539957A4 (en) | Novel diagnostic and therapeutic methods and reagents therefor | |
| EP1517879A4 (en) | Aminoalkylphenols, methods of using and making the same | |
| GB0200757D0 (en) | Diagnostic methods | |
| AU2003214667A1 (en) | Elastic ruler for herb therapy and the therapy method for disease using the same | |
| AU2003273152A1 (en) | Receptor and screening methods | |
| AU2003268661A1 (en) | Diagnostic and examination method for eating disorder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |